Comparison of Clinical Profiles, Demographics, and Surgical Outcomes of 25-Gauge Vitrectomy for Proliferative Diabetic Retinopathy in Young Adults with Type 1 or Type 2 Diabetes

Purpose Proliferative diabetic retinopathy (PDR) is a leading cause of poor vision in young adults. This study sought to evaluate the clinical characteristics and outcomes of primary vitrectomy for PDR in young adults. Patients and Methods Medical data were retrospectively collected at a large ophthalmology hospital in China. We analyzed data for 99 patients (140 eyes) aged <45 years with T1D or T2D who underwent primary vitrectomy for PDR-related complications. Results There were 18 patients with T1D and 81 patients with T2D. The proportion of males was significantly greater than that of females in both groups. The T1D group had a longer duration of diabetes (P = 0.008), younger age at primary vitrectomy (P = 0.049), and lower body mass index (P < 0.001) than the T2D group. The proportion of eyes with rhegmatogenous retinal detachment (RRD) was greater but the proportion of eyes with traction retinal detachment (TRD) was lower in the T1D group than in the T2D group. The final best-corrected visual acuity (BCVA) improved or remained stable in 100% and 85.3% of eyes and decreased in 0% and 14.7% of eyes in the T1D and T2D groups, respectively. After surgery, the incidence of postoperative complications was significant greater in the T2D group than in the T1D group (P = 0.045). Factors influencing the final visual acuity included preoperative BCVA in both groups, the duration of diabetes (P = 0.031) and preoperative FVP (P = 0.004) in the T1D group, and preoperative RRD (P < 0.001) and postoperative NVG (P < 0.001) in the T2D group. Conclusion In this retrospective study, young adults with T2D who underwent vitrectomy had worse final visual acuity and more complications than young adults with T1D.

[1]  Ting Zhang,et al.  Clinical Characteristics and Surgical Outcomes of Complications of Proliferative Diabetic Retinopathy in Young versus Older Patients with Type 2 Diabetes , 2023, Diabetes, metabolic syndrome and obesity : targets and therapy.

[2]  Jiyang Tang,et al.  Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients , 2022, Ophthalmology and Therapy.

[3]  Wei Wang,et al.  Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes , 2022, BMJ Open.

[4]  D. Hodge,et al.  Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period. , 2021, JAMA ophthalmology.

[5]  R. Channa,et al.  Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management , 2021, Current Diabetes Reports.

[6]  K. Ramasamy,et al.  Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study , 2021, Indian journal of ophthalmology.

[7]  A. Galli-Tsinopoulou,et al.  Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents , 2021, World journal of diabetes.

[8]  W. Wong,et al.  Incidence and clinical characteristics of pediatric‐onset type 2 diabetes in Hong Kong: The Hong Kong childhood diabetes registry 2008 to 2017 , 2021, Pediatric diabetes.

[9]  C. Wykoff,et al.  Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy , 2021, Diabetes Care.

[10]  H. Yamashita,et al.  Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy , 2021, PloS one.

[11]  Rui Zeng,et al.  The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy , 2020, European journal of ophthalmology.

[12]  Wei Zhang,et al.  Trends and geographic variations in self‐reported diabetes incidence: A prospective open cohort study of Chinese men and women, 1997–2015 , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Bo Huang,et al.  Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients , 2020, BMC Ophthalmology.

[14]  C. Marcus,et al.  Microalbuminuria and retinopathy in adolescents and young adults with type 1 and type 2 diabetes , 2020, Pediatric diabetes.

[15]  T. Y. A. Liu,et al.  Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center , 2020, Pediatric diabetes.

[16]  R. Kowluru Retinopathy in a Diet-Induced Type 2 Diabetic Rat Model and Role of Epigenetic Modifications , 2020, Diabetes.

[17]  Zhi-zhong Ma,et al.  Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy. , 2020, Annals of Palliative Medicine.

[18]  Till Bärnighausen,et al.  Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 , 2018, Diabetes Care.

[19]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[20]  Chung-May Yang,et al.  Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  R. D. Gross,et al.  Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus , 2016, Pediatric Clinical Practice Guidelines & Policies.

[22]  D. Maberley,et al.  ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis , 2015, Retina.

[23]  D. Witherspoon,et al.  Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study , 2015, Diabetology & Metabolic Syndrome.

[24]  Jasmin Divers,et al.  Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. , 2014, JAMA.

[25]  H. Mugishima,et al.  Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. , 2012, Pediatric endocrinology reviews : PER.

[26]  D. Yorston,et al.  Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy , 2008, British Journal of Ophthalmology.

[27]  Chung-May Yang,et al.  Extended Silicone Oil Tamponade in Primary Vitrectomy for Complex Retinal Detachment in Proliferative Diabetic Retinopathy: A Long-Term Follow-Up Study , 2007, European journal of ophthalmology.

[28]  L. Chuang,et al.  National surveillance for type 2 diabetes mellitus in Taiwanese children. , 2003, JAMA.

[29]  M. Blumenkranz,et al.  Silicone oil for the treatment of severe proliferative diabetic retinopathy. , 1989, Ophthalmology.

[30]  Junfen Fu,et al.  Changing Epidemiology of Metabolic Syndrome and Type 2 Diabetes in Chinese Youth , 2013, Current Diabetes Reports.

[31]  D. Power Standards of medical care in diabetes. , 2006, Diabetes care.